The store will not work correctly when cookies are disabled.
US9062043, Table 20b, Compound 8
ID: ALA3700567
Cas Number: 1009821-08-2
PubChem CID: 57664043
Max Phase: Preclinical
Molecular Formula: C19H12ClFN4O2
Molecular Weight: 382.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1ccc2c(c1)nc(Nc1ccc(F)c(Cl)c1)c1ncncc12
Standard InChI: InChI=1S/C19H12ClFN4O2/c1-27-19(26)10-2-4-12-13-8-22-9-23-17(13)18(25-16(12)6-10)24-11-3-5-15(21)14(20)7-11/h2-9H,1H3,(H,24,25)
Standard InChI Key: XJYPFCRZPRXEHU-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
3.6331 -3.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1953 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1932 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4896 -3.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4844 -5.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1828 -6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1786 -7.2040 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.8863 -5.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8450 -5.8459 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-3.8915 -3.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1962 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1962 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 3.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
3 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
17 19 1 0
19 20 1 0
19 21 2 0
21 14 1 0
12 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 8 1 0
27 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 382.78 | Molecular Weight (Monoisotopic): 382.0633 | AlogP: 4.50 | #Rotatable Bonds: 3 |
Polar Surface Area: 77.00 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.39 | CX LogP: 4.37 | CX LogD: 4.37 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.41 | Np Likeness Score: -1.61 |
References
1. (2015) Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators, |